The Patent Finder

Cellerant Therapeutics, Inc.

Also on record
Records under this name other than patents Cellerant Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cellerant Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,715,619Compositions and methods for treating haematological proliferative disorders of myeloid origin
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,371,390Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,631,026Antibodies That Specifically Bind to TIM3
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,301,394Antibodies That Specifically Bind to TIM3
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,723,805Antibodies specific for CLL-1
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,163,090Antibodies specific for CLL-1
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,850,314Antibodies specific for CLL-1
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,072,662Humanized anti-CLL-1 antibodies
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,359,025Anti-IL1-RAP antibodies
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,841,418Antibodies That Specifically Bind to TIM3
Formerly held
Lapsed on the fee record
Ended Sep 23, 2026 · High confidence
Lapsed on the fee recordEnded Sep 23, 2026High confidence
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited